The allergic asthma disease state was induced by the administration of 40 μg OVA (ovalbumin) and 1 μg human TSLP intranasally into mice in groups B, C, D, and E every other day for two weeks, while mice in group A received PBS treatment as a sham control (Figure 6A). The gene discussed is TSLP; the disease is allergic asthma.